Skip to content

MAZE MAZE Current ratio

Current ratio at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
+0.4×
Septerna, Inc. logo
Septerna, Inc.SEPN
4.7×-27.5×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
+0.6×
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
10.9×-4.3×
Zymeworks logo
ZymeworksZYME
10.8×+6.1×
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-0.3×

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
Operating cash flow-$39.1M-32.5%
CapEx$93.0K-68.9%
Free cash flow-$39.2M-31.5%

Valuation

See full
Market cap$1.48B
Enterprise value$1.34B
P/S7.9×

Profitability

See full
Operating margin-71.5%
Net margin-65.4%
FCF margin-65.1%

Returns & leverage

See full
Return on equity-38.7%
Debt / equity0.2×+0.1×

Where this comes from

Calculated from MAZE’s reported figures.

Based on the most recent quarter.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MAZE's current ratio?
MAZE (MAZE) reported current ratio of 17.9× in Q1 2026.
How has MAZE's current ratio changed year-over-year?
MAZE's current ratio increased by 11.1% year-over-year, from 16.1× to 17.9×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.